GT Biopharma Enters Into $7.45M Private Placement of Preferred Stock and Warrants

Filing content

GT Biopharma entered into a securities purchase agreement for the issuance of Series M convertible preferred stock and common stock warrants for aggregate gross proceeds of $7.45 million.